Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 151

    1.

    Testicular dysgenesis syndrome and the estrogen hypothesis: a quantitative meta-analysis.

    Martin OV, Shialis T, Lester JN, Scrimshaw MD, Boobis AR, Voulvoulis N.

    Environ Health Perspect. 2008 Feb;116(2):149-57. Review.PMID: 18288311 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Testicular dysgenesis syndrome and the estrogen hypothesis: a quantitative meta-analysis.

    Martin O, Shialis T, Lester J, Scrimshaw M, Boobis A, Voulvoulis N.

    Cien Saude Colet. 2008 Sep-Oct;13(5):1601-18.PMID: 18813661 [PubMed]Related articlesFree article

    3.

    Association between testicular dysgenesis syndrome (TDS) and testicular neoplasia: evidence from 20 adult patients with signs of maldevelopment of the testis.

    Skakkebaek NE, Holm M, Hoei-Hansen C, Jørgensen N, Rajpert-De Meyts E.

    APMIS. 2003 Jan;111(1):1-9; discussion 9-11.PMID: 12752226 [PubMed - indexed for MEDLINE]Related articles

    4.

    Testicular dysgenesis syndrome: possible role of endocrine disrupters.

    Bay K, Asklund C, Skakkebaek NE, Andersson AM.

    Best Pract Res Clin Endocrinol Metab. 2006 Mar;20(1):77-90. Review.PMID: 16522521 [PubMed - indexed for MEDLINE]Related articles

    5.

    The 'oestrogen hypothesis'- where do we stand now?

    Sharpe RM.

    Int J Androl. 2003 Feb;26(1):2-15. Review.PMID: 12534932 [PubMed - indexed for MEDLINE]Related articles

    6.

    Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects.

    Sharpe RM, Skakkebaek NE.

    Fertil Steril. 2008 Feb;89(2 Suppl):e33-8. Review.PMID: 18308057 [PubMed - indexed for MEDLINE]Related articles

    7.

    In utero exposure to di(n-butyl) phthalate and testicular dysgenesis: comparison of fetal and adult end points and their dose sensitivity.

    Mahood IK, Scott HM, Brown R, Hallmark N, Walker M, Sharpe RM.

    Environ Health Perspect. 2007 Dec;115 Suppl 1:55-61.PMID: 18174951 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Male reproductive disorders in humans and prenatal indicators of estrogen exposure. A review of published epidemiological studies.

    Storgaard L, Bonde JP, Olsen J.

    Reprod Toxicol. 2006 Jan;21(1):4-15. Epub 2005 Jul 6. Review.PMID: 16005180 [PubMed - indexed for MEDLINE]Related articles

    9.

    Testicular dysgenesis syndrome and the development and occurrence of male reproductive disorders.

    Virtanen HE, Rajpert-De Meyts E, Main KM, Skakkebaek NE, Toppari J.

    Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):501-5. Review.PMID: 16005920 [PubMed - indexed for MEDLINE]Related articles

    10.

    Estrogen receptor alpha is a major contributor to estrogen-mediated fetal testis dysgenesis and cryptorchidism.

    Cederroth CR, Schaad O, Descombes P, Chambon P, Vassalli JD, Nef S.

    Endocrinology. 2007 Nov;148(11):5507-19. Epub 2007 Aug 2.PMID: 17673513 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Testicular dysgenesis syndrome: foetal origin of adult reproductive problems.

    Wohlfahrt-Veje C, Main KM, Skakkebaek NE.

    Clin Endocrinol (Oxf). 2009 Oct;71(4):459-65. Epub 2009 Feb 16.PMID: 19222487 [PubMed - in process]Related articles

    12.

    Are estrogens carcinogenic during development of the testes?

    McLachlan JA, Newbold RR, Li S, Negishi M.

    APMIS. 1998 Jan;106(1):240-2; discussion 243-4. Review.PMID: 9524585 [PubMed - indexed for MEDLINE]Related articles

    13.

    Does a testicular dysgenesis syndrome exist?

    Akre O, Richiardi L.

    Hum Reprod. 2009 Sep;24(9):2053-60. Epub 2009 May 14. Review.PMID: 19443456 [PubMed - indexed for MEDLINE]Related articles

    14.

    Environment, testicular dysgenesis and carcinoma in situ testis.

    Olesen IA, Sonne SB, Hoei-Hansen CE, Rajpert-DeMeyts E, Skakkebaek NE.

    Best Pract Res Clin Endocrinol Metab. 2007 Sep;21(3):462-78. Review.PMID: 17875492 [PubMed - indexed for MEDLINE]Related articles

    15.

    The RsaI polymorphism in the estrogen receptor-beta gene is associated with male infertility.

    Aschim EL, Giwercman A, Ståhl O, Eberhard J, Cwikiel M, Nordenskjöld A, Haugen TB, Grotmol T, Giwercman YL.

    J Clin Endocrinol Metab. 2005 Sep;90(9):5343-8. Epub 2005 Jul 5.PMID: 15998774 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Testicular dysgenesis syndrome.

    Skakkebaek NE.

    Horm Res. 2003;60 Suppl 3:49.PMID: 14671395 [PubMed - indexed for MEDLINE]Related articles

    17.

    Ethnic differences in occurrence of TDS-- genetics and/or environment?

    Giwercman A, Rylander L, Hagmar L, Giwercman YL.

    Int J Androl. 2006 Feb;29(1):291-7; discussion 304-6. Review.PMID: 16466550 [PubMed - indexed for MEDLINE]Related articles

    18.

    Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects.

    Skakkebaek NE, Rajpert-De Meyts E, Main KM.

    Hum Reprod. 2001 May;16(5):972-8. Review.PMID: 11331648 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Cryptorchidism as part of the testicular dysgenesis syndrome: the environmental connection.

    Main KM, Skakkebaek NE, Toppari J.

    Endocr Dev. 2009;14:167-73. Epub 2009 Feb 27. Review.PMID: 19293583 [PubMed - indexed for MEDLINE]Related articles

    20.

    Insulin-like factor 3 gene mutations in testicular dysgenesis syndrome: clinical and functional characterization.

    Ferlin A, Bogatcheva NV, Gianesello L, Pepe A, Vinanzi C, Agoulnik AI, Foresta C.

    Mol Hum Reprod. 2006 Jun;12(6):401-6. Epub 2006 May 10.PMID: 16687567 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data